Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quzyttir vs Diphenhydramine in Acute Urticaria
NCT02935699Phase 3Completed
- Sponsor
- JDP Therapeutics
- Start
- Mar 2017
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of cetirizine in acute urticaria, sponsored by JDP Therapeutics. Started Mar 2017; status: completed.
02
Drugs
cetirizine
03
Conditions
acute urticaria
Beyond the preview
Go deeper on NCT02935699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02935699.